“…Recently, the lifespan extending drug, metformin, was shown to protect the lung from oxidative stress by inhibiting the activity of the mitochondrial complex I leading to a reduction in reactive oxygen species (ROS) emergent from the complex I machinery (35,38,39). It is now apparent that changes in the cellular transcriptome (3,7,40), proteome (7,40), stress-related PN pathways (2,6,17,41) and mitochondrial pathways (12,(34)(35)(36)39,(42)(43)(44)(45)(46) can have complex effects on the functionality of the lung (19,(47)(48)(49)(50)(51). However, the nature of the age-associated changes that contribute to the differential sensitivity of young and old lungs to influenza and resulting pneumonia pathophysiology remain enigmatic.…”